Taher, A. T. Et Al. 2016. Optimizing Iron Chelation Therapy with Deferasirox in Patients with Non-Transfusion-Dependent Thalassemia: 1-Year Results from the Phase 4, Open-Label THETIS Study. AABB Annual Meeting , (Florida, United States Of America).

Taher, A. T., Cappellini, M., Aydinok, Y., Porter, J., Karakas, Z., Viprakasit, V., ... Siritanaratkul, N.(2016). Optimizing Iron Chelation Therapy with Deferasirox in Patients with Non-Transfusion-Dependent Thalassemia: 1-Year Results from the Phase 4, Open-Label THETIS Study . AABB Annual Meeting, Florida, United States Of America

Taher, A. Et Al. "Optimizing Iron Chelation Therapy with Deferasirox in Patients with Non-Transfusion-Dependent Thalassemia: 1-Year Results from the Phase 4, Open-Label THETIS Study," AABB Annual Meeting, Florida, United States Of America, 2016

Taher, A. T. Et Al. "Optimizing Iron Chelation Therapy with Deferasirox in Patients with Non-Transfusion-Dependent Thalassemia: 1-Year Results from the Phase 4, Open-Label THETIS Study." AABB Annual Meeting , Florida, United States Of America, 2016

Taher, A. T. Et Al. (2016) . "Optimizing Iron Chelation Therapy with Deferasirox in Patients with Non-Transfusion-Dependent Thalassemia: 1-Year Results from the Phase 4, Open-Label THETIS Study." AABB Annual Meeting , Florida, United States Of America.

@conferencepaper{conferencepaper, author={A. T. Taher Et Al. }, title={Optimizing Iron Chelation Therapy with Deferasirox in Patients with Non-Transfusion-Dependent Thalassemia: 1-Year Results from the Phase 4, Open-Label THETIS Study}, congress name={AABB Annual Meeting}, city={Florida}, country={United States Of America}, year={2016}}